Glaxo Said to Have Paid $1 Billion Over Paxil Suits

GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements.

Glaxo Said to Have Paid $1 Billion Over Paxil Suits